M Abele - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Abele

Showing results (61-70 of 71) with videos related to

Pageof 8

Sort By:

Medizinische Monatsschrift Fur Pharmazeuten|July 12, 2002

[Rational use of oral antibiotics in children and young people. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy ]Horst Scholz, Friedrich Vogel, M Abele-Horn, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999

Brain : a Journal of Neurology|October 8, 1998

Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3T Klockgether, M Skalej, D Wedekind, et al.

Brain : a Journal of Neurology|May 13, 1998

The natural history of degenerative ataxia: a retrospective study in 466 patientsT Klockgether, R Lüdtke, B Kramer, et al.

Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004

L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trialL Schöls, J Zange, M Abele, et al.

Annals of the New York Academy of Sciences|April 14, 2005

Saccade velocity as a surrogate disease marker in spinocerebellar ataxia type 2C Seifried, L Velázquez-Pérez, N Santos-Falcón, et al.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 10, 2009

Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2L Velázquez-Pérez, C Seifried, M Abele, et al.

Pneumologie (Stuttgart, Germany)|January 18, 2018

[Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology]K Dalhoff, M Abele-Horn, S Andreas, et al.

Pneumologie (Stuttgart, Germany)|December 11, 2012

[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia. S-3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy]K Dalhoff, M Abele-Horn, S Andreas, et al.

Pneumologie (Stuttgart, Germany)|May 15, 2018

[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa]C Schwarz, B Schulte-Hubbert, J Bend, et al.

Pageof 8

Search research articles

Showing results (61-70 of 71) with videos related to

Sort By:

Pageof 8

Medizinische Monatsschrift Fur Pharmazeuten|July 12, 2002

[Rational use of oral antibiotics in children and young people. Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy ]Horst Scholz, Friedrich Vogel, M Abele-Horn, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999

Brain : a Journal of Neurology|October 8, 1998

Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3T Klockgether, M Skalej, D Wedekind, et al.

Brain : a Journal of Neurology|May 13, 1998

The natural history of degenerative ataxia: a retrospective study in 466 patientsT Klockgether, R Lüdtke, B Kramer, et al.

Journal of Neural Transmission (Vienna, Austria : 1996)|October 14, 2004

L-carnitine and creatine in Friedreich's ataxia. A randomized, placebo-controlled crossover trialL Schöls, J Zange, M Abele, et al.

Annals of the New York Academy of Sciences|April 14, 2005

Saccade velocity as a surrogate disease marker in spinocerebellar ataxia type 2C Seifried, L Velázquez-Pérez, N Santos-Falcón, et al.

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|February 10, 2009

Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2L Velázquez-Pérez, C Seifried, M Abele, et al.

Pneumologie (Stuttgart, Germany)|January 18, 2018

Pneumologie (Stuttgart, Germany)|December 11, 2012

Pneumologie (Stuttgart, Germany)|May 15, 2018

[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa]C Schwarz, B Schulte-Hubbert, J Bend, et al.

Pageof 8